Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation - PubMed (original) (raw)
Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation
K M Kaye et al. Proc Natl Acad Sci U S A. 1993.
Abstract
The gene encoding latent-infection membrane protein 1 (LMP1) was specifically mutated in Epstein-Barr virus (EBV) recombinants by inserting a nonsense linker after codon 9 or codon 84 or into an intron 186 bp 3' to the latter insertion site. EBV recombinants with the LMP1 intron mutation were wild type for LMP1 expression and for growth transformation of primary B lymphocytes. In contrast, EBV recombinants with the mutations in the LMP1 open reading frame expressed N-terminally truncated crossreactive proteins and could initiate or maintain primary B-lymphocyte transformation only when wild-type LMP1 was provided in trans by a coinfecting, transformation-defective EBV, P3HR-1. These data indicate that LMP1 is essential for EBV-mediated transformation of primary B lymphocytes, that the first 43 amino acids are critical for LMP1's function, and that codon 44-initiated LMP1 does not have a dominant negative effect on transformation.
Similar articles
- The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation.
Izumi KM, Kaye KM, Kieff ED. Izumi KM, et al. Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1447-52. doi: 10.1073/pnas.94.4.1447. Proc Natl Acad Sci U S A. 1997. PMID: 9037073 Free PMC article. - An Epstein-Barr virus with a 58-kilobase-pair deletion that includes BARF0 transforms B lymphocytes in vitro.
Robertson ES, Tomkinson B, Kieff E. Robertson ES, et al. J Virol. 1994 Mar;68(3):1449-58. doi: 10.1128/JVI.68.3.1449-1458.1994. J Virol. 1994. PMID: 8107208 Free PMC article. - Epstein-barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-kappaB.
Cahir McFarland ED, Izumi KM, Mosialos G. Cahir McFarland ED, et al. Oncogene. 1999 Nov 22;18(49):6959-64. doi: 10.1038/sj.onc.1203217. Oncogene. 1999. PMID: 10602470 Review. - The Latent Membrane Protein 1 (LMP1).
Kieser A, Sterz KR. Kieser A, et al. Curr Top Microbiol Immunol. 2015;391:119-49. doi: 10.1007/978-3-319-22834-1_4. Curr Top Microbiol Immunol. 2015. PMID: 26428373 Review.
Cited by
- TRAF binding is required for a distinct subset of in vivo B cell functions of the oncoprotein LMP1.
Arcipowski KM, Bishop GA. Arcipowski KM, et al. J Immunol. 2012 Dec 1;189(11):5165-70. doi: 10.4049/jimmunol.1201821. Epub 2012 Oct 29. J Immunol. 2012. PMID: 23109728 Free PMC article. - Inhibition of latent membrane protein 1 impairs the growth and tumorigenesis of latency II Epstein-Barr virus-transformed T cells.
Ndour PA, Brocqueville G, Ouk TS, Goormachtigh G, Morales O, Mougel A, Bertout J, Melnyk O, Fafeur V, Feuillard J, Coll J, Adriaenssens E. Ndour PA, et al. J Virol. 2012 Apr;86(7):3934-43. doi: 10.1128/JVI.05747-11. Epub 2012 Jan 18. J Virol. 2012. PMID: 22258264 Free PMC article. - An Epstein-Barr virus isolated from a lymphoblastoid cell line has a 16-kilobase-pair deletion which includes gp350 and the Epstein-Barr virus nuclear antigen 3A.
Lee W, Hwang YH, Lee SK, Subramanian C, Robertson ES. Lee W, et al. J Virol. 2001 Sep;75(18):8556-68. doi: 10.1128/jvi.75.18.8556-8568.2001. J Virol. 2001. PMID: 11507201 Free PMC article. - Intracellular signaling molecules activated by Epstein-Barr virus for induction of interferon regulatory factor 7.
Zhang L, Wu L, Hong K, Pagano JS. Zhang L, et al. J Virol. 2001 Dec;75(24):12393-401. doi: 10.1128/JVI.75.24.12393-12401.2001. J Virol. 2001. PMID: 11711629 Free PMC article. - The late lytic LMP-1 protein of Epstein-Barr virus can negatively regulate LMP-1 signaling.
Erickson KD, Martin JM. Erickson KD, et al. J Virol. 2000 Jan;74(2):1057-60. doi: 10.1128/jvi.74.2.1057-1060.2000. J Virol. 2000. PMID: 10623774 Free PMC article.
References
- J Virol. 1988 Nov;62(11):4173-84 - PubMed
- J Gen Virol. 1988 May;69 ( Pt 5):1051-65 - PubMed
- Nature. 1989 Aug 3;340(6232):393-7 - PubMed
- N Engl J Med. 1989 Oct 19;321(16):1080-5 - PubMed
- Proc Natl Acad Sci U S A. 1989 Dec;86(23):9558-62 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials